Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
Recruiting · NCT07561554 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation | Solid Tumors (Phase 1) | Recruiting | Phase 1 | 2026-05-01 | NCT07561554 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haisco Pharmaceutical Group Co., Ltd. | 50 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Beijing Tiantan Hospital,Capital Medical University | Beijing | China | 6 |